Hematology Continuing Education

Continuing Education on Hematology

The recent years have witnessed major advances in the treatment of benign rare blood disorders such as hemophilia, sickle cell disease (SCD), and cold agglutinin disease (CAD). Moreover, new guidelines have been developed for the diagnosis and management of these blood disorders. Clinicians including hematologists and emergency department physicians need to remain up to date on the various aspects of management of these hematological disorders to diagnose, treat, and manage associated complications. Moreover, access to novel therapies remains challenging due to payer restrictions including step therapy policies. Hematologists and their care team need education on streamlining the prior authorization processes to prevent treatment delays.

Hematology CE/CME Activities

The CME Outfitters Hematology Hub is designed to provide clinicians with the latest clinical practice guidelines, diagnostic strategies and tools, scientific updates on current and emerging therapies, latest guidelines to optimize the management of hematological disorders, and strategies to streamline prior authorization process. In addition, the Hematology Hub also provides patient education tools to empower patients to make informed decisions about their care and to navigate the prior authorization process.

One Size Does Not Fit All: Using Population Pharmacokinetics for Tailored Hemophilia Care

Participate NowIn order to prevent and treat bleeding in patients with hemophilia A, the activity of the replaced clotting factor VIII must reach or exceed a target level over a period of time. Pharmacokinetic (PK) measures are therefore used to determine the dosing regimen of the different factor VIII replacement products. Recently, extended half-life recombinant factor VIII products with improved PK profiles have been approved and these reduce treatment burden and improve treatment adherence. In this CME Outfitters live and on-demand webcast, renowned hematologists will discuss the clinical significance of the results of the head-to-head comparison study of PK profiles of extended half-life factor VIII products including the application of population PK models and shared decision-making to provide personalized hemophilia A therapy.  Credit is no longer available for this activity, but it can still be accessed for on-demand learning.

Management of Hemophilia in the Emergency Department: A Case-Based Discussion

Participate NowThis CME Outfitters LLC Snack features case-based learning designed to facilitate problem-solving and therefore bridge the gap between evidence and actionable changes in practice as they pertain to updated guidelines, new treatments, and emerging therapies that will help physicians and other professionals who work in the emergency department with identifying, monitoring, and managing patients with hemophilia.  Credit is no longer available for this activity, but it can still be accessed for on-demand learning.

Management of Sickle Cell Disease in the Emergency Department: A Case-Based Discussion

Participate NowThis CME Outfitters Snack is included in the 3-part series on management of benign rare blood disorders in the emergency department. It features a video physician-patient case scenario with hematological insights on the evaluation and management of patients in the ED and current and emerging treatments for sickle cell disease.  Credit is no longer available for this activity, but it can still be accessed for on-demand learning.